High false-positive results from routine penicillin skin testing influencing the choice of appropriate antibiotics in China

China is one of the largest producers and consumers of antibiotics [ [1] Yin J. Wang Y. Xu X. Liu Y. Yao L. Sun Q. The progress of global antimicrobial resistance governance and its implication to China: a review. Antibiotics. 2021; 10: 1356 Crossref Scopus (9) Google Scholar ]. However, use of the ‘Access’ group of antibiotics (a category of safe, affordable and available antibiotics) in China remains extremely low, especially in children [ [2] Hsia Y. Lee B.R. Versporten A. Yang Y. Bielicki J. Jackson C. et al. Use of the WHO Access, Watch, and Reserve classification to define patterns of hospital antibiotic use (AWaRe): an analysis of paediatric survey data from 56 countries. Lancet Glob Health. 2019; 7: e861-e871 Abstract Full Text Full Text PDF PubMed Scopus (153) Google Scholar ], and is far below the World Health Organization's (WHO) target to combat global antimicrobial resistance (AMR), namely that Access antibiotics should represent at least 60% of overall antibiotic consumption by 2030.